IP Verse

Androgen Receptor Modulator And Uses Thereof

Patent No. EP2945628 (titled "Androgen Receptor Modulator And Uses Thereof") was filed by Aragon Pharmaceuticals on Jan 9, 2014. The application was issued on Apr 15, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKJan 15, 2021ELKINGTON AND FIFE
MAIWALDJan 15, 2021-
SYNTHONJan 15, 2021HAMM & WITTKOPP
TEVA PHARMACEUTICALSJan 15, 2021D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2945628

ARAGON PHARMACEUTICALS
Application Number
EP14701865A
Filing Date
Jan 9, 2014
Status
Revoked
Sep 24, 2021
Publication Date
Apr 15, 2020
External Links
Slate, Register , Google Patents